{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:05:31Z","timestamp":1790867131543,"version":"4.1.0"},"reference-count":100,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian Dermatol Online J"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/idoj.idoj_561_19","type":"journal-article","created":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T04:40:47Z","timestamp":1638765647000},"page":"482","source":"Crossref","is-referenced-by-count":43,"title":["What is new in the pathogenesis and management of erythema nodosum leprosum"],"prefix":"10.4103","volume":"11","author":[{"given":"RameshM","family":"Bhat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TanviP","family":"Vaidya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2229-5178.289635-1","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.sder.2007.02.010","article-title":"Erythema nodosum leprosum: Reactional leprosy","author":"Cuevas","year":"2007","journal-title":"Semin Cutan Med Surg"},{"key":"key-10.4103\/2229-5178.289635-2","doi-asserted-by":"crossref","first-page":"868","DOI":"10.4269\/ajtmh.2006.74.868","article-title":"Clinical course of erythema nodosum leprosum: An 11-year cohort study in Hyderabad, India","author":"Pocaterra","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.4103\/2229-5178.289635-3","first-page":"297","article-title":"Nerve function impairment in leprosy at diagnosis and at completion of MDT: A retrospective cohort study of 786 patients in Bangladesh","author":"Richardus","year":"2015","journal-title":"Lepr Rev"},{"key":"key-10.4103\/2229-5178.289635-4","first-page":"318","article-title":"ENL reactions in the multibacillary cases of the AMFES cohort in central Ethiopia: Incidence and risk factors","author":"Saunderson","year":"2000","journal-title":"Lepr Rev"},{"key":"key-10.4103\/2229-5178.289635-5","doi-asserted-by":"crossref","unstructured":"Voorend CGN, Post EB. A systematic review on the epidemiological data of erythema nodosum leprosum, a type 2 leprosy reaction. PLoS Negl Trop Dis 2013;7.","DOI":"10.1371\/journal.pntd.0002440"},{"key":"key-10.4103\/2229-5178.289635-6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1590\/S0036-46651998000600005","article-title":"Reactional states in multibacillary hansen disease patients during multidrug therapy","author":"Nery","year":"1998","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"key-10.4103\/2229-5178.289635-7","first-page":"270","article-title":"Risk factors for erythema nodosum leprosum","author":"Manandhar","year":"1999","journal-title":"Int J Lepr"},{"key":"key-10.4103\/2229-5178.289635-8","first-page":"235","article-title":"Two multidrug fixed-dosage treatment regimens with multibacillary leprosy patients","author":"Gallo","year":"1996","journal-title":"Indian J Lepr"},{"key":"key-10.4103\/2229-5178.289635-9","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1346-8138.2004.tb00623.x","article-title":"A study of leprosy reactions in a tertiary hospital in Delhi","author":"Sharma","year":"2004","journal-title":"J Dermatol"},{"key":"key-10.4103\/2229-5178.289635-10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.47276\/lr.82.3.213","article-title":"Does clofazimine prevent erythema nodosum leprosum (ENL) in leprosy.A retrospective study, comparing the experience of multibacillary patients receiving either 12 or 24 months WHO-MDT?","author":"Balagon","year":"2011","journal-title":"Lepr Rev"},{"key":"key-10.4103\/2229-5178.289635-11","first-page":"257","article-title":"Changing profile of disease in leprosy patients diagnosed in a tertiary care centre during years 1995-2000","author":"Arora","year":"2008","journal-title":"Indian J Lepr"},{"key":"key-10.4103\/2229-5178.289635-12","first-page":"129","article-title":"The association of pregnancy and leprosy-III.Erythema nodosum leprosum in pregnancy and lactation","author":"Duncan","year":"1984","journal-title":"Lepr Rev"},{"key":"key-10.4103\/2229-5178.289635-13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1590\/S0365-05962008000100010","article-title":"Leprosy type 1 reactions and erythema nodosum leprosum","author":"Kahawita","year":"2008","journal-title":"An Bras Dermatol"},{"key":"key-10.4103\/2229-5178.289635-14","first-page":"325","article-title":"Hospital-based epidemiological study of reactions, Buluba Hospital, 1985-89","author":"Bwire","year":"1993","journal-title":"Lepr Rev"},{"key":"key-10.4103\/2229-5178.289635-15","first-page":"559","article-title":"Epidemiologic characteristics of leprosy reactions","author":"Scollard","year":"1994","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"key-10.4103\/2229-5178.289635-16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1489\/1544-581X(2004)072<0125:ECOLRY>2.0.CO;2","article-title":"Epidemiological characteristics of leprosy reactions: 15 years experience from North India","author":"Kumar","year":"2004","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"key-10.4103\/2229-5178.289635-17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1346-8138.1988.tb04079.x","article-title":"Reactions in leprosy.A prospective study of clinical, bacteriological, immunological and histopathological parameters in thirty-five Indians","author":"Sehgal","year":"1988","journal-title":"J Dermatol"},{"key":"key-10.4103\/2229-5178.289635-18","doi-asserted-by":"crossref","first-page":"637","DOI":"10.4269\/ajtmh.2010.09-0586","article-title":"Reactions following completion of 1 and 2 year multidrug therapy (MDT)","author":"Balagon","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.4103\/2229-5178.289635-19","first-page":"405","article-title":"Long-term follow up of multibacillary leprosy patients with high BI treated with WHO\/MDT regimen for a fixed duration of two years","author":"Shaw","year":"2000","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"key-10.4103\/2229-5178.289635-20","unstructured":"Schreuder PA. The occurrence of reactions and impairments in leprosy: Experience in the leprosy control program of three provinces in northeastern Thailand (1987-1995). II. Reactions. Int J Lepr Other Mycobact Dis 1998;66:149-58."},{"key":"key-10.4103\/2229-5178.289635-21","doi-asserted-by":"crossref","unstructured":"Silva SF, Griep RH. Leprosy reaction in patients of health centers from the planning area 3.2. of Rio de Janeiro municipality. Hansenol Int2007;32:155-62.","DOI":"10.47878\/hi.2007.v32.36301"},{"key":"key-10.4103\/2229-5178.289635-22","first-page":"29","article-title":"A retrospective study of the severe and uncommon variants of erythema nodosum leprosum at a tertiary health center in central India","author":"Wankhade","year":"2019","journal-title":"Int J Mycobacteriol","ISSN":"https:\/\/id.crossref.org\/issn\/2212-5531","issn-type":"print"},{"key":"key-10.4103\/2229-5178.289635-23","first-page":"28","article-title":"Thehistopathology and histochemistry of erythema nodosum leprosum","author":"Mabalay","year":"1965","journal-title":"IntJLepr"},{"key":"key-10.4103\/2229-5178.289635-24","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1086\/650318","article-title":"Integrated pathways for neutrophil recruitment and inflammation in leprosy","author":"Lee","year":"2010","journal-title":"J Infect Dis"},{"key":"key-10.4103\/2229-5178.289635-25","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.thromres.2007.05.013","article-title":"Neutrophil CD64 expression is associated with severity and prognosis of disseminated intravascular coagulation","author":"Song","year":"2008","journal-title":"Thromb Res"},{"key":"key-10.4103\/2229-5178.289635-26","doi-asserted-by":"crossref","first-page":"e0004955","DOI":"10.1371\/journal.pntd.0004955","article-title":"Expression of CD64 on circulating neutrophils favoring systemic inflammatory status in erythema nodosum leprosum","author":"Schmitz","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.4103\/2229-5178.289635-27","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/jlb.65.3.364","article-title":"Neutrophils isolated from leprosy patients release TNF-\u03b1 and exhibit accelerated apoptosis in vitro","author":"Oliveira","year":"1999","journal-title":"J Leukoc Biol"},{"key":"key-10.4103\/2229-5178.289635-28","first-page":"233","article-title":"A systematic review of immunological studies of erythema nodosum leprosum","author":"Polycarpou","year":"2017","journal-title":"Front Immunol"},{"key":"key-10.4103\/2229-5178.289635-29","first-page":"933","article-title":"Erythema nodosum leprosum: Aclinical manifestation of the arthus phenomenon","author":"Wemambu","year":"2003","journal-title":"Lancet"},{"key":"key-10.4103\/2229-5178.289635-30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1574-695X.1997.tb01073.x","article-title":"IgM anti-phenolic glycolipid I and IgG anti-10-kDa heat shock protein antibodies in sera and immune complexes isolated from leprosy patients with or without erythema nodosum leprosum and contacts","author":"Rojas","year":"1997","journal-title":"FEMS Immunol Med Microbiol"},{"key":"key-10.4103\/2229-5178.289635-31","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3389\/fimmu.2017.01149","article-title":"New insight into the pathogenesis of erythema nodosum leprosum: The role of activated memory T-cells","author":"Negera","year":"2017","journal-title":"Front Immunol"},{"key":"key-10.4103\/2229-5178.289635-32","first-page":"491","article-title":"Studies on T cell subsets and functions in leprosy","author":"Bach","year":"1981","journal-title":"ClinExpImmunol"},{"key":"key-10.4103\/2229-5178.289635-33","first-page":"282","article-title":"Imbalances in T cell subpopulations in lepromatous leprosy","author":"Wallach","year":"1982","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"key-10.4103\/2229-5178.289635-34","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/j.1365-4632.2010.04535.x","article-title":"Circulating CD4+CD25highFoxP3+T cells vary in different clinical forms of leprosy","author":"Attia","year":"2010","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/2229-5178.289635-35","first-page":"217","article-title":"Regulatory T-cells at the interface between human host and pathogens in infectious diseases and vaccination","author":"Boer","year":"2015","journal-title":"Front Immunol"},{"key":"key-10.4103\/2229-5178.289635-36","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1086\/498216","article-title":"Effective treatment of erythema nodosum leprosum with thalidomide is associated with immune stimulation","author":"Haslett","year":"2005","journal-title":"J Infect Dis"},{"key":"key-10.4103\/2229-5178.289635-37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1471-2334-9-75","article-title":"Potential plasma markers of type 1 and type 2 leprosy reactions: A preliminary report","author":"Stefani","year":"2009","journal-title":"BMC Infect Dis"},{"key":"key-10.4103\/2229-5178.289635-38","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1056\/NEJMc052955","article-title":"Treatment of recurrent erythema nodosum leprosum with infliximab","author":"Faber","year":"2006","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2229-5178.289635-39","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijmyco.2016.02.002","article-title":"Treatment of severe refractory erythema nodosum leprosum with tumor necrosis factor inhibitor Etanercept","author":"Chowdhry","year":"2016","journal-title":"Int J Mycobacteriol","ISSN":"https:\/\/id.crossref.org\/issn\/2212-5531","issn-type":"print"},{"key":"key-10.4103\/2229-5178.289635-40","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1128\/iai.60.4.1441-1446.1992","article-title":"Tumor necrosis factor production in patients with leprosy","author":"Barnes","year":"1992","journal-title":"Infect Immun"},{"key":"key-10.4103\/2229-5178.289635-41","first-page":"181089","article-title":"Leprosy: An overview of pathophysiology","author":"Bhat","year":"2012","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"key-10.4103\/2229-5178.289635-42","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1084\/jem.175.6.1729","article-title":"Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients","author":"Sampaio","year":"1992","journal-title":"J Exp Med"},{"key":"key-10.4103\/2229-5178.289635-43","doi-asserted-by":"crossref","first-page":"371","DOI":"10.47276\/lr.82.4.371","article-title":"Serum cytokine profile in leprosy and its correlation with clinico-histopathological profile","author":"Madan","year":"2011","journal-title":"Lepr Rev"},{"key":"key-10.4103\/2229-5178.289635-44","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1046\/j.1365-4362.1998.00382.x","article-title":"Cytokines in leprosy, II.Effect of treatment on serum cytokines in leprosy","author":"Moubasher","year":"1998","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/2229-5178.289635-45","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.trstmh.2008.01.004","article-title":"Towards understanding the pathology of erythema nodosum leprosum","author":"Kahawita","year":"2008","journal-title":"Trans R Soc Trop MedHyg"},{"key":"key-10.4103\/2229-5178.289635-46","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/infdis\/jis208","article-title":"Genetic and immunological evidence implicates interleukin 6 as a susceptibility gene for leprosy type 2 reaction","author":"Sousa","year":"2012","journal-title":"J Infect Dis"},{"key":"key-10.4103\/2229-5178.289635-47","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1086\/599121","article-title":"Polymorphism N248S in the human Toll-like receptor 1 gene is related to leprosy and leprosy reactions","author":"Schuring","year":"2009","journal-title":"J Infect Dis"},{"key":"key-10.4103\/2229-5178.289635-48","first-page":"4184","article-title":"Response to comment on \u201cDNA sensing via TLR-9 constitutes a major innate immunity pathway activated during erythema nodosum leprosum","author":"Pereira","year":"8221","journal-title":"Response"},{"key":"key-10.4103\/2229-5178.289635-49","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1371\/journal.pntd.0000231","article-title":"Human TLR1 deficiency is associated with impaired mycobacterial signaling and protection from leprosy reversal reaction","author":"Misch","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.4103\/2229-5178.289635-50","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1590\/S0074-02762012000900020","article-title":"Genetics of leprosy reactions: An overview","author":"Fava","year":"2012","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"key-10.4103\/2229-5178.289635-51","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1590\/S0037-86822010000300014","article-title":"NRAMP1 gene polymorphisms in individuals with leprosy reactions attended at two reference centers in Recife, northeastern Brazil","author":"Teixeira","year":"2010","journal-title":"Rev Soc Bras Med Trop"},{"key":"key-10.4103\/2229-5178.289635-52","doi-asserted-by":"crossref","first-page":"739","DOI":"10.4103\/0378-6323.120719","article-title":"New insights in the pathogenesis of type 1 and type 2 lepra reaction","author":"Pandhi","year":"2013","journal-title":"Indian J Dermatol Venereol"},{"key":"key-10.4103\/2229-5178.289635-53","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1046\/j.1365-2249.1996.d01-860.x","article-title":"Erythema nodosum leprosum is associated with up-regulation of polyclonal IgG1 antibody synthesis","author":"Kifayet","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"key-10.4103\/2229-5178.289635-54","first-page":"105","article-title":"Selective Decrease of M.leprae-Specific IgG1 and IgG3 antibodies in leprosy patients associated with ENL","author":"Kifayet","year":"1996","journal-title":"Int J Lepr"},{"key":"key-10.4103\/2229-5178.289635-55","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1093\/infdis\/jiu612","article-title":"Transcriptional changes that characterize the immune reactions of leprosy","author":"Dupnik","year":"2015","journal-title":"J Infect Dis"},{"key":"key-10.4103\/2229-5178.289635-56","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.mjafi.2012.02.010","article-title":"Bullous erythema nodosum leprosum","author":"Vashisht","year":"2013","journal-title":"Med J Armed Forces India"},{"key":"key-10.4103\/2229-5178.289635-57","first-page":"12","article-title":"Necrotic erythema nodosum leprosum","author":"Rai","year":"2006","journal-title":"Dermatol Online J"},{"key":"key-10.4103\/2229-5178.289635-58","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/0378-6323.104682","article-title":"Bullous lesions in leprosy: A rare phenomenon","author":"Agarwal","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/2229-5178.289635-59","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1111\/j.1365-3156.2007.01951.x","article-title":"Utility of measuring serum levels of anti-PGL-I antibody, neopterin and C-reactive protein in monitoring leprosy patients during multi-drug treatment and reactions","author":"Silva","year":"2007","journal-title":"Trop Med Int Heal"},{"key":"key-10.4103\/2229-5178.289635-60","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1590\/S1413-86702007000300016","article-title":"Vasculonecrotic reactions in leprosy","author":"Fogagnolo","year":"2007","journal-title":"Brazilian J Infect Dis"},{"key":"key-10.4103\/2229-5178.289635-61","first-page":"429698","article-title":"Leprosy mimicking common rheumatologic entities: A trial for the clinician in the era of biologics","author":"Rath","year":"2014","journal-title":"Case Rep Rheumatol"},{"key":"key-10.4103\/2229-5178.289635-62","first-page":"76","article-title":"A study of rheumatological manifestations of leprosy","author":"VengadakrishnanK,","year":"2004","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/2229-5178.289635-63","first-page":"275","article-title":"Leprosy presenting as rheumatoid arthritis","author":"Lele","year":"1965","journal-title":"J Assoc Physicians India"},{"key":"key-10.4103\/2229-5178.289635-64","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/1756-185X.13023","article-title":"Leprosy in the rheumatology clinic: An update on this great mimic","author":"Gupta","year":"2016","journal-title":"Int J Rheum Dis"},{"key":"key-10.4103\/2229-5178.289635-65","doi-asserted-by":"crossref","first-page":"e2690","DOI":"10.1371\/journal.pntd.0002690","article-title":"The mortality associated with erythema nodosum leprosum in Ethiopia: A retrospective hospital-based study","author":"Walker","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.4103\/2229-5178.289635-66","doi-asserted-by":"crossref","first-page":"e0005716","DOI":"10.1371\/journal.pntd.0005716","article-title":"Erythema Nodosum Leprosum International Study Group.A leprosy clinical severity scale for erythema nodosum leprosum: An international, multicentre validation study of the ENLIST ENL Severity Scale","author":"Walker","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.4103\/2229-5178.289635-67","doi-asserted-by":"crossref","first-page":"332","DOI":"10.47276\/lr.87.3.332","article-title":"The development of a severity scale for Erythema Nodosum Leprosum \u2013 the ENLIST ENL severity scale","author":"Walker","year":"2016","journal-title":"Lepr Rev"},{"key":"key-10.4103\/2229-5178.289635-68","doi-asserted-by":"crossref","first-page":"328","DOI":"10.47276\/lr.74.4.328","article-title":"Treatment duration of reversal reaction: A reappraisal.Back to the past","author":"Naafs","year":"2003","journal-title":"Lepr Rev"},{"key":"key-10.4103\/2229-5178.289635-69","first-page":"53","article-title":"The \u201cEllis\u201d and \u201cRyrie\u201d tests","author":"Naafs","year":"1987","journal-title":"Lepr Rev"},{"key":"key-10.4103\/2229-5178.289635-70","first-page":"222","article-title":"Clinical and histological discrepancies in diagnosis of ENL reactions classified by assessment of acute phase proteins SAA and CRP","author":"Hussain","year":"1995","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"key-10.4103\/2229-5178.289635-71","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4103\/0019-5154.94278","article-title":"A retrospective analysis of histopathology of 64 cases of lepra reactions","author":"Adhe","year":"2012","journal-title":"Indian J Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/0019-5154","issn-type":"print"},{"key":"key-10.4103\/2229-5178.289635-72","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4103\/0971-9903.138439","article-title":"Fine needle aspiration cytology of lymph node in erythema nodosum leprosum: A case report with review of literature","author":"Hungund","year":"2014","journal-title":"J Mahatma Gandhi Inst Med Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0971-9903","issn-type":"print"},{"key":"key-10.4103\/2229-5178.289635-73","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/infdis\/jix267","article-title":"Elevated pentraxin-3 concentrations in patients with leprosy: Potential biomarker of erythema nodosum leprosum","author":"Mendes","year":"2017","journal-title":"J Infect Dis"},{"key":"key-10.4103\/2229-5178.289635-74","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1099\/jmm.0.016394-0","article-title":"Alpha1-acid glycoprotein as a putative biomarker for monitoring the development of the type II reactional stage of leprosy","author":"Gupta","year":"2010","journal-title":"J Med Microbiol"},{"key":"key-10.4103\/2229-5178.289635-75","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3389\/fimmu.2019.00495","article-title":"Neutrophils in leprosy","author":"Schmitz","year":"2019","journal-title":"Front Immunol"},{"key":"key-10.4103\/2229-5178.289635-76","doi-asserted-by":"crossref","unstructured":"Negera E, Walker S, Lemma T, Aseffa A, Lockwood D, Dockrell H. Complement C1q expression in Erythema nodosum leprosum. PLoS Negl Trop Dis 12.","DOI":"10.1371\/journal.pntd.0006321"},{"key":"key-10.4103\/2229-5178.289635-77","doi-asserted-by":"crossref","first-page":"223","DOI":"10.47276\/lr.78.3.223","article-title":"Circulating cytokine profiles in leprosy patients","author":"Belgaumkar","year":"2007","journal-title":"Lepr Rev"},{"key":"key-10.4103\/2229-5178.289635-78","doi-asserted-by":"crossref","first-page":"e0005396","DOI":"10.1371\/journal.pntd.0005396","article-title":"Leprosy reactions: The predictive value ofMycobacterium leprae-specific serology evaluated in a Brazilian cohort of leprosy patients (U-MDT\/CT-BR)","author":"Hungria","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.4103\/2229-5178.289635-79","first-page":"253","article-title":"The management of erythema nodosum leprosum: Current and future options","author":"Lockwood","year":"1996","journal-title":"Lepr Rev"},{"key":"key-10.4103\/2229-5178.289635-80","first-page":"355","article-title":"Interventions for erythema nodosum leprosum","author":"Van","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/2229-5178.289635-81","first-page":"29","article-title":"The use of pentoxifylline in the treatment of type 2 reactional episodes in leprosy","author":"Nery","year":"2000","journal-title":"Indian J Lepr"},{"key":"key-10.4103\/2229-5178.289635-82","first-page":"51","article-title":"Oral zinc therapy in recurrent erythema nodosum leprosum: A clinical study","author":"Mahajan","year":"1994","journal-title":"Indian J Lepr"},{"key":"key-10.4103\/2229-5178.289635-83","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.actatropica.2018.02.026","article-title":"Erythema nodosum leprosum: Update and challenges on the treatment of a neglected condition","author":"Costa","year":"2018","journal-title":"Acta Trop"},{"key":"key-10.4103\/2229-5178.289635-84","doi-asserted-by":"crossref","first-page":"142","DOI":"10.47276\/lr.90.2.142","article-title":"A systematic review of adverse drug reactions associated with Thalidomide in the treatment of Erythema Nodosum Leprosum","author":"Mahmoud","year":"2019","journal-title":"Lepr Rev"},{"key":"key-10.4103\/2229-5178.289635-85","first-page":"8181507","article-title":"Deep venous thrombosis in patients with Erythema Nodosum Leprosum in the use of thalidomide and systemic corticosteroid in reference service in Belo Horizonte, Minas Gerais","author":"Porto","year":"2019","journal-title":"Case Rep Dermatol Med"},{"key":"key-10.4103\/2229-5178.289635-86","first-page":"1","article-title":"Expert committee on leprosy.Eigth Report","author":"The","year":"2012","journal-title":"World Health Organ Tech Rep Ser"},{"key":"key-10.4103\/2229-5178.289635-87","first-page":"12","article-title":"Role of clofazimine in management of reactions in leprosy: A brief overview","author":"Pai","year":"2015","journal-title":"Indian J Drugs Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/2455-3972","issn-type":"print"},{"key":"key-10.4103\/2229-5178.289635-88","doi-asserted-by":"crossref","first-page":"290","DOI":"10.47276\/lr.78.3.290","article-title":"Azathioprine in controlling type 2 reactions in leprosy: Acase report","author":"Athreya","year":"2007","journal-title":"Lepr Rev"},{"key":"key-10.4103\/2229-5178.289635-89","doi-asserted-by":"crossref","first-page":"304","DOI":"10.47276\/lr.82.3.304","article-title":"Azathioprine as a steroid sparing agent in leprosy type 2 reactions: Report of nine cases","author":"Duraes","year":"2011","journal-title":"Lepr Rev"},{"key":"key-10.4103\/2229-5178.289635-90","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.4049\/jimmunol.137.11.3620","article-title":"Effect of cyclosporine A in erythema nodosum leprosum","author":"Uyemura","year":"1986","journal-title":"J Immunol"},{"key":"key-10.4103\/2229-5178.289635-91","first-page":"117","article-title":"Potential of thalidomide and thalidomide analogues as immunomodulatory drugs in leprosy and leprosy reactions","author":"Kaplan","year":"2015","journal-title":"Lepr Rev"},{"key":"key-10.4103\/2229-5178.289635-92","doi-asserted-by":"crossref","first-page":"917","DOI":"10.18203\/issn.2455-4529.IntJResDermatol20194697","article-title":"Biologics in dermatology","author":"Oka","year":"2019","journal-title":"Int J Res Dermatol"},{"key":"key-10.4103\/2229-5178.289635-93","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/cid\/ciq213","article-title":"Severe refractory erythema nodosum leprosum successfully treated with the tumor necrosis factor inhibitor etanercept","author":"Ramien","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/2229-5178.289635-94","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/art.24632","article-title":"Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French research axed on tolerance of biotherapies registry","author":"Tubach","year":"2009","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/2229-5178.289635-95","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1001\/jamadermatol.2015.0384","article-title":"Minocycline for recurrent and\/or chronic erythema nodosum leprosum","author":"Narang","year":"2015","journal-title":"JAMA Dermatol"},{"key":"key-10.4103\/2229-5178.289635-96","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bph.12139","article-title":"Minocycline: Far beyond an antibiotic","author":"Garrido-MesaN,","year":"2013","journal-title":"Br J Pharmacol"},{"key":"key-10.4103\/2229-5178.289635-97","first-page":"1","article-title":"Apremilast in psoriasis and beyond: Big hopes on a small molecule","author":"Afra","year":"2019","journal-title":"Indian Dermatol Online J","ISSN":"https:\/\/id.crossref.org\/issn\/2229-5178","issn-type":"print"},{"key":"key-10.4103\/2229-5178.289635-98","doi-asserted-by":"crossref","unstructured":"Narang T, Kaushik A, Dogra S. Apremilast in chronic recalcitrant erythema nodosum leprosum: Areport of two cases. Br J Dermatol2019;18233.doi: 10.1111\/bjd. 18233.","DOI":"10.1111\/bjd.18233"},{"key":"key-10.4103\/2229-5178.289635-99","first-page":"7","article-title":"Immunotherapy with Mycobacterium w vaccine decreases the incidence and severity of type 2 (ENL) reactions","author":"Zaheer","year":"1993","journal-title":"Lepr Rev"},{"key":"key-10.4103\/2229-5178.289635-100","first-page":"164","article-title":"Potential anti-leprosy vaccine from killed ICRC bacilli-a clinico-pathological study","author":"Deo","year":"1981","journal-title":"Ind J Med Res"}],"container-title":["Indian Dermatology Online Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:24:47Z","timestamp":1787163887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.IDOJ_561_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":100,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"alternative-id":["289635"],"URL":"https:\/\/doi.org\/10.4103\/idoj.idoj_561_19","relation":{},"ISSN":["2229-5178"],"issn-type":[{"value":"2229-5178","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}